Page last updated: 2024-09-05

cirsimaritin and sitagliptin

cirsimaritin has been researched along with sitagliptin in 1 studies

Compound Research Comparison

Studies
(cirsimaritin)
Trials
(cirsimaritin)
Recent Studies (post-2010)
(cirsimaritin)
Studies
(sitagliptin)
Trials
(sitagliptin)
Recent Studies (post-2010) (sitagliptin)
4902197070

Protein Interaction Comparison

ProteinTaxonomycirsimaritin (IC50)sitagliptin (IC50)
Chain A, Dipeptidyl peptidase IVHomo sapiens (human)0.018
Dipeptidyl peptidase 4Rattus norvegicus (Norway rat)0.0255
Thromboxane-A synthase Homo sapiens (human)0.0194
Dipeptidyl peptidase 4Homo sapiens (human)0.0236
Dipeptidyl peptidase 4Mus musculus (house mouse)0.046
Prolyl endopeptidase FAPHomo sapiens (human)2.93
Dipeptidyl peptidase 8Homo sapiens (human)0.4715
Dipeptidyl peptidase 9Homo sapiens (human)1.539
Dipeptidyl peptidase 2Homo sapiens (human)0.022

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ1

Reviews

1 review(s) available for cirsimaritin and sitagliptin

ArticleYear
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship

2018